Polianta Ltd maintained its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,700 shares of the pharmacy operator’s stock at the close of the 2nd quarter. Polianta Ltd’s holdings in Walgreens Boots Alliance were worth $994,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently modified their holdings of WBA. Russell Investments Group Ltd. raised its holdings in shares of Walgreens Boots Alliance by 72.9% in the 1st quarter. Russell Investments Group Ltd. now owns 482,962 shares of the pharmacy operator’s stock valued at $40,115,000 after acquiring an additional 203,635 shares in the last quarter. Wellington Management Group LLP raised its holdings in shares of Walgreens Boots Alliance by 5.9% in the 1st quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after acquiring an additional 1,824,300 shares in the last quarter. Sumitomo Mitsui Asset Management Company LTD raised its holdings in shares of Walgreens Boots Alliance by 9.3% in the 1st quarter. Sumitomo Mitsui Asset Management Company LTD now owns 75,821 shares of the pharmacy operator’s stock valued at $6,296,000 after acquiring an additional 6,462 shares in the last quarter. Welch & Forbes LLC raised its holdings in shares of Walgreens Boots Alliance by 4.8% in the 1st quarter. Welch & Forbes LLC now owns 96,882 shares of the pharmacy operator’s stock valued at $8,046,000 after acquiring an additional 4,453 shares in the last quarter. Finally, Credit Agricole S A raised its holdings in shares of Walgreens Boots Alliance by 28.7% in the 1st quarter. Credit Agricole S A now owns 1,113,816 shares of the pharmacy operator’s stock valued at $92,502,000 after acquiring an additional 248,165 shares in the last quarter. 60.18% of the stock is currently owned by institutional investors and hedge funds.

Several research firms have weighed in on WBA. BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday. Zacks Investment Research cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, June 14th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a report on Thursday, September 7th. Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a report on Sunday. Finally, UBS AG reaffirmed a “buy” rating and issued a $96.00 price target (down previously from $97.00) on shares of Walgreens Boots Alliance in a report on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $91.81.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the sale, the director now directly owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded up 0.22% during trading on Wednesday, reaching $82.92. The company had a trading volume of 2,648,058 shares. Walgreens Boots Alliance, Inc. has a one year low of $75.18 and a one year high of $89.69. The firm’s 50 day moving average is $80.98 and its 200 day moving average is $82.02. The company has a market capitalization of $88.73 billion, a PE ratio of 20.94 and a beta of 1.26.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The business had revenue of $30.12 billion for the quarter, compared to the consensus estimate of $29.72 billion. During the same period in the prior year, the business posted $1.18 earnings per share. The company’s quarterly revenue was up 2.1% compared to the same quarter last year. On average, equities research analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current year.

Walgreens Boots Alliance announced that its Board of Directors has initiated a share repurchase plan on Thursday, June 29th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to purchase up to 5.9% of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s board of directors believes its stock is undervalued.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th were given a dividend of $0.40 per share. The ex-dividend date was Wednesday, August 16th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a yield of 1.93%. Walgreens Boots Alliance’s dividend payout ratio is 40.30%.

COPYRIGHT VIOLATION WARNING: This piece of content was published by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright legislation. The original version of this piece of content can be accessed at https://www.dailypolitical.com/2017/09/13/walgreens-boots-alliance-inc-wba-holdings-held-by-polianta-ltd.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.